Goodbody Health Limited

Goodbody Health Limited

GDBYF
Goodbody Health LimitedUS flagOther OTC
0.00
USD
- -
- -
365.00Market Cap
Goodbody Health Limited
GDBYF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2016
2017
2018
2019
2019
2020
2020
2021
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.18
0.02
0.12
0.49
0.45
Revenue per Share
-0.52
-0.12
-0.16
-0.35
-0.08
-0.08
-0.18
-0.17
-2.35
-0.48
-1.73
-0.29
-0.07
-0.1
Basic EPS, GAAP
-4.98
-1.19
-0.15
-0.3
-0.06
-0.06
-0.01
-0.04
-0.89
-0.39
-0.54
-0.16
0.05
-0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
4.22
-0.25
-0.37
-0.56
-0.71
-0.71
0.08
-0.06
4.61
0.2
0.42
0.2
0.09
0.01
Book Value per Share
4.8
1.09
0.77
0.11
0.25
0.25
0.13
0.02
2.32
0.37
0.55
0.3
0.19
0.13
Tangible Book Value per Share
- -
- -
- -
1
1
1
1
2
5
8
11
16
35
36
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
2
17
16
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
-13,163.71
-245.12
-1,460.14
-230.23
-6.19
-11.44
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
-13
-4
-19
-5
-2
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
-23,173.11
-261.99
-7,118.5
-233.61
-13.57
-22.61
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
10
2
3
1
4
2
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
27
4
6
6
7
5
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-28.29
-610.19
-117.73
-72.24
-148.93
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'22
Jun'22
Sep'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
36
36
36
Market Capitalization
- -
- -
1

Working Capital

FRC

in mil. unless spec.
Mar'22
Jun'22
Sep'22
Total Current Assets
7
5
4
Cash, Cash Equivalents & STI
6
4
3
Accounts Receivable, Net
- -
- -
- -
Inventories
1
1
- -
Total Current Liabilities
4
2
2
Payables & Accruals
3
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
13,671.02%
12.47%
Free Cash Flow
- -
1,099.28%
-161.76%
Net Income, GAAP
- -
759.27%
-50.32%
Sales/Revenue/Turnover
- -
- -
755.37%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
1
- -
- -
2
2021
1
3
5
7
17
2022
5
2
2
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.04
- -
- -
- -
-0.29
2021
-0.04
-0.01
- -
- -
-0.07
2022
-0.01
-0.03
-0.03
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Business
Goodbody Health Limited operates as a wellness entity, delivering an extensive array of health and wellness solutions across the United Kingdom and continental Europe. The company functions as a comprehensive cannabinoid (CBD) enterprise, managing operations that span extraction facilities, bulk isolate and distillate distribution, retail and white-label CBD product sales, and sophisticated cannabinoid laboratory testing services. Beyond its CBD initiatives, Goodbody Health has established a prominent presence in diagnostic wellness testing, offering a wide spectrum of services including blood, genome, and various other health assessments through its network of clinics, which also historically provided COVID testing services. Recently, the company has expanded its phlebotomy services by partnering with external testing providers and enhancing its clinic infrastructure to support preventative health management. Goodbody Health Limited, which was previously known as Sativa Wellness Group Inc. and later Goodbody Health Inc., transitioned its corporate domicile from Canada to Guernsey in August 2022. The company's principal executive offices are now located in Guernsey.

Company News

APIChatGPT